EMA to Review New Safety Data on Alzheimer’s Drug Leqembi

This post was originally published on Medscape

You will shortly be re-directed to the publisher's website

The reassessment of Leqembi’s safety data follows the agency’s previous recommendation of the drug for use in the EU.
Medscape Medical News